# A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain

> **NCT01490905** · PHASE4 · COMPLETED · sponsor: **Targeted Medical Pharma** · enrollment: 127 (actual)

## Conditions studied

- Chronic Low Back Pain

## Interventions

- **OTHER:** Theramine (A medical food)
- **DRUG:** Theraprofen
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT01490905
- **Lead sponsor:** Targeted Medical Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-02
- **Final completion:** 2011-04
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2011-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490905, "A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01490905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*